Chemomab Therapeutics Ltd. (CMMB)
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
Address
KIRYAT ATIDIM, BUILDING 7
TEL AVIV, L3 6158002
Founded
2011
Number of Employees
20
Website
http://www.chemomab.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | - | $1,213 | - | - | $1,213 |
| Average Price | - | - | - | - | - | - | - | - | $2.08 | - | - | $2.08 |
| # Shares Purchased | - | - | - | - | - | - | - | - | 582,023 | - | - | 582,023 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | - | -52.0% | - | - | -52.0% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | - | 37.3% | - | - | 37.3% |
| Excess Total Return | - | - | - | - | - | - | - | - | -89.3% | - | - | -89.3% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | - | 11% | - | - | 13% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at CMMB make a trade.
Creating a free account takes less than one minute